Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Teal Valley T.TV


Primary Symbol: P.TEAL

Teal is a Canadian, pharmaceutical & NHP manufacturer selling to Canada’s national, chain drug stores, presently expanding its portfolio to include cannabinoid-based products utilizing proprietary formulations & extractions for both the global Rx & recreational markets.


P.TEAL - Post by User

Post by LuvtoInveston Feb 23, 2021 6:36pm
264 Views
Post# 32642963

No need of further dilution

No need of further dilutionFor RP2.0, TV requires $93M. Construction to start in Q1 2022. So we can safely assume that whatever extra cash TV generates in 2021 and in 2022 H1 can go towards $93M required for the project.

I have used the information released by TV through its corporate presentation, press releases, financials and MDAs in arriving at the following analysis. The only assumption I have made is that TV enters into forward swap for balance of 2021 production (which is not yet forward swapped) and 2022 H1 production. I have done this because this is the worst case scenario. Actually I beleive that TV should not enter into any further forward swaps since I expect Zinc prices to go up in 2021 and 2022. Based on this worst case scenario, TV can spare/put aside $68.31M cash in 2021 and $34.87M cash in 2022 H1 for RP2.0. This comes to a total of $103.19M. 

Of course, whether TV will actaully meet its 2021 projections or not is a different story. Also, what the management will actually do in terms of dilution or no further dilution is also a seperate story.

Forward Swaps Months Qty/Mth Total Qty Price Value
    (Mlbs) (Mlbs) ($/lb) ($)
Jan - Mar 2021 3 3.750 11.25 1.10 12.38
Jan - Mar 2021 3 2.500 7.50 1.12 8.40
Apr - Dec 2021 9   59.50 1.23 73.19
Apr - Dec 2021 9   49.29 1.25 61.61
Total     127.54   155.57
Average Price         1.22
           
2021 Zinc Production Guidance - Midpoint     345.00    
Balance Left after Forward Swap     217.46    
Assuming TV sells balance at today's price     217.46 1.29 280.53
Total for the year     345.00   436.10
Average Price for the year         1.26
           
Projected Annual Margin above AISC of 0.90       1.25 117.00
           
Projected Annual Margin above AISC of 0.90       1.26 118.31
           
Sustaining capital expenditure         39.00
Exploration capital expenditure         6.00
Expansionary capital expenditure         5.00
Total expenditure out of Annual Margin         50.00
           
Cash that can be spared for RP2.0 in 2021         68.31
           
2022 Zinc Production Guidance - Assumption     345.00    
2022 - H1 Production     172.50    
If TV sells 2022 H1 Production at today's price     172.50 1.29 222.53
           
Projected 2022 H1 Margin above AISC of 0.90       1.25 58.50
           
Projected 2022 H1 Margin above AISC of 0.90       1.29 60.37
           
Sustaining capital expenditure         19.50
Exploration capital expenditure         6.00
Total expenditure out of Annual Margin         25.50
           
Cash that can be spared for RP2.0 in 2022 H1         34.87
           
Total Cash that can be spared for RP2.0 upto 2022 H1       103.19
  
<< Previous
Bullboard Posts
Next >>